446 related articles for article (PubMed ID: 14871421)
41. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease.
Ramos LF; Kane J; McMonagle E; Le P; Wu P; Shintani A; Ikizler TA; Himmelfarb J
J Ren Nutr; 2011 May; 21(3):211-8. PubMed ID: 21185738
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of chronic kidney disease in orthotopic heart transplant recipients and kidney allograft recipients using the new Chronic Kidney Disease Epidemiology Collaboration formula.
Malyszko J; Przybylowski P; Malyszko JS; Iaina-Levin N; Sadowski J; Mysliwiec M
Transplant Proc; 2010 Dec; 42(10):4251-4. PubMed ID: 21168676
[TBL] [Abstract][Full Text] [Related]
43. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
44. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients.
Cottone S; Mulè G; Guarneri M; Palermo A; Lorito MC; Riccobene R; Arsena R; Vaccaro F; Vadalà A; Nardi E; Cusimano P; Cerasola G
Nephrol Dial Transplant; 2009 Feb; 24(2):497-503. PubMed ID: 18772174
[TBL] [Abstract][Full Text] [Related]
45. Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study.
Sarnak MJ; Poindexter A; Wang SR; Beck GJ; Kusek JW; Marcovina SM; Greene T; Levey AS
Kidney Int; 2002 Dec; 62(6):2208-15. PubMed ID: 12427147
[TBL] [Abstract][Full Text] [Related]
46. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
47. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
Boaz M; Iuliano L; Himmelfarb J; Matas Z; Micheletta F; McMonagle E; Friedman V; Natoli S; Gvirtz G; Biro A; Smetana S; Sabo G; Gafter U; Weinstein T
Nephron Clin Pract; 2005; 100(4):c111-9. PubMed ID: 15849477
[TBL] [Abstract][Full Text] [Related]
48. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy.
Agarwal R
BMC Nephrol; 2005 Nov; 6():13. PubMed ID: 16303055
[TBL] [Abstract][Full Text] [Related]
49. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
[TBL] [Abstract][Full Text] [Related]
50. Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality.
Lobo JC; Stockler-Pinto MB; Farage NE; Faulin Tdo E; Abdalla DS; Torres JP; Velarde LG; Mafra D
Ren Fail; 2013; 35(5):680-5. PubMed ID: 23650973
[TBL] [Abstract][Full Text] [Related]
51. Oxidative stress is increased in critically ill patients with acute renal failure.
Himmelfarb J; McMonagle E; Freedman S; Klenzak J; McMenamin E; Le P; Pupim LB; Ikizler TA; The PICARD Group
J Am Soc Nephrol; 2004 Sep; 15(9):2449-56. PubMed ID: 15339994
[TBL] [Abstract][Full Text] [Related]
52. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
[TBL] [Abstract][Full Text] [Related]
53. Analysis of early kidney damage in hospitalized patients with chronic kidney disease: a multicenter study.
Chen N; Pan XX; Gu Y; Mao PJ; Ni ZH; Ding XQ; Zhang JH; Wang NS; Yuan WJ; Zhang JY
Ren Fail; 2012; 34(3):329-33. PubMed ID: 22250704
[TBL] [Abstract][Full Text] [Related]
54. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
Yu YM; Hou FF; Zhang X; Zhou H; Liu ZQ
Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
[TBL] [Abstract][Full Text] [Related]
55. The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease.
van Kuijk JP; Flu WJ; Chonchol M; Welten GM; Verhagen HJ; Bax JJ; Poldermans D
Nephrol Dial Transplant; 2010 Jun; 25(6):1882-8. PubMed ID: 20061315
[TBL] [Abstract][Full Text] [Related]
56. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
57. Diet, inflammation, and chronic kidney disease: getting to the heart of the matter.
Neade T; Uribarri J
Semin Dial; 2008; 21(4):331-7. PubMed ID: 18573134
[TBL] [Abstract][Full Text] [Related]
58. Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease.
Il'yasova D; Ivanova A; Morrow JD; Cesari M; Pahor M
Biomarkers; 2008 Feb; 13(1):41-51. PubMed ID: 17852073
[TBL] [Abstract][Full Text] [Related]
59. Impact of Kidney Transplantation on Biomarkers of Oxidative Stress and Inflammation.
Soleymanian T; Ranjbar A; Alipour M; Ganji MR; Najafi I
Iran J Kidney Dis; 2015 Sep; 9(5):400-5. PubMed ID: 26338165
[TBL] [Abstract][Full Text] [Related]
60. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.
Kaysen GA; Eiserich JP
J Am Soc Nephrol; 2004 Mar; 15(3):538-48. PubMed ID: 14978155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
